Tricuspid valve surgery in implantable cardiac electronic device-related endocarditis: Repair or replace?

Çakıcı, Mehmet; Özçınar, Evren; Baran, Çağdaş; Gümüş, Fatih; Durdu, Mustafa Serkan; İnan, Mustafa; Eryilmaz, Sadık; Akar, Ahmet

doi:10.5606/tgkdc.dergisi.2018.14790

Cited by 4 publications

(1 citation statement)

References 22 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The treatment of right sided endocarditis related to CIED is an emergent field (8,49,54) and recent reports are suggesting as delay in decision-making and lack of experience in this filed may result in intraprocedural and postoperative complications (67). The aim of surgery is to remove the infection, restore competence of the TV and reduce the risk of bacterial pulmonary embolism during removal of the infection.…”

Section: Surgery: Technical Considerationsmentioning

confidence: 99%

The quest for the optimal surgical management of tricuspid valve endocarditis in the current era: a narrative review

Nappi¹,

Spadaccio²,

Mihos

et al. 2020

Ann Transl Med

View full text Add to dashboard Cite

Tricuspid valve endocarditis (TVE) is a growing concern with increasing rates and mortality burden. The currently changing etiology, the antibiotic resistance and the raise in iatrogenic causes as with implantable cardiac devices [cardiac implantable electronic device (CIED)], represent a challenge for the management of these patients. The progressively widespread use of CIEDs is adding to the more commonly known intravenous (IV) drug abuse in the list of causes. Treatment strategies include medical therapy alone or surgery. From the surgical standpoint tricuspid valve repair, replacement or the staged procedure of valvectomy as bridge to replacement are available options. Treatment of endocarditis related to implantable device is another expanding field which requires a coordinated action with microbiologists in consideration of the microorganism antibiotic resistance. This review summarizes the currently available evidences on TVE including surgical indications, timing of interventions and technical considerations. The conflicting results of the available observational evidences and the non-unanimous consensus on many aspects of TVE impede to reach a definitive conclusion regarding the best management strategy and demands for randomized studies in this field.

show abstract

Section: Surgery: Technical Considerationsmentioning

confidence: 99%

The quest for the optimal surgical management of tricuspid valve endocarditis in the current era: a narrative review

Nappi¹,

Spadaccio²,

Mihos

et al. 2020

Ann Transl Med

View full text Add to dashboard Cite

show abstract

A Systematic Review and Meta-Analysis of the Clinical Outcomes of Isolated Tricuspid Valve Surgery

Chick

Alkhalil

Egred

et al. 2023

The American Journal of Cardiology

View full text Add to dashboard Cite

The New Challenge for Heart Endocarditis: From Conventional Prosthesis to New Devices and Platforms for the Treatment of Structural Heart Disease

Nappi

Iervolino

Singh

2021

BioMed Research International

View full text Add to dashboard Cite

Infective endocarditis is a sinister condition with considerable morbidity and mortality. Its relevance in the current era is compounded by the increased use of implanted devices such as replacement valves or cardiac implantable electronic devices. These infections are caused by multiple different bacteria with different virulence, pathogenicity, and antimicrobial resistance. Unlike in native endocarditis, the presence of foreign tissue permits sustenance by inflammatory and thrombotic processes as the artificial surfaces promote inflammatory responses and hypercoagulability. Prevention of these infections has been suggested with the use of homografts in combination with antibiotics. Others have attempted to use “low fouling coats” with little clinical success thus far. The use of antibiotic prophylaxis plays a pivotal part in reducing the incidence of prosthesis-related endocarditis. This remains especially crucial with the increasing use of transcatheter heart valve therapies. The widespread use of cardiac implantable electronic devices such as permanent pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices has also heralded a noticeable increase in cases of infectious endocarditis affecting complex equipment which can be difficult to treat. Multimodality strategies are needed with input from surgeons and cardiologists to ensure treatment is both prompt and successful, tailored to the individual needs of the patients.

show abstract

Tricuspid valve surgery in implantable cardiac electronic device-related endocarditis: Repair or replace?

Cited by 4 publications

References 22 publications

The quest for the optimal surgical management of tricuspid valve endocarditis in the current era: a narrative review

The quest for the optimal surgical management of tricuspid valve endocarditis in the current era: a narrative review

A Systematic Review and Meta-Analysis of the Clinical Outcomes of Isolated Tricuspid Valve Surgery

The New Challenge for Heart Endocarditis: From Conventional Prosthesis to New Devices and Platforms for the Treatment of Structural Heart Disease

Contact Info

Product

Resources

About